Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target (2012)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- Subjects: ARTERIOSCLEROSE; DOENÇAS CARDIOVASCULARES; INSUFICIÊNCIA RENAL CRÔNICA; METALOPROTEINASES; UREMIA
- Language: Inglês
- Imprenta:
- Publisher place: West Sussex
- Date published: 2012
- Source:
- Título do periódico: Basic and Clinical Pharmacology and toxicology
- ISSN: 1742-7851
- Volume/Número/Paginação/Ano: v. 110, n. 5, p. 409-415, 2012
-
ABNT
MARSON, Bernardo P.; FIGUEIREDO, Carlos E. Poli de; SANTOS, José Eduardo Tanus dos. Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target. Basic and Clinical Pharmacology and toxicology, West Sussex, v. 110, n. 5, p. 409-415, 2012. Disponível em: < http://dx.doi.org/10.1111/j.1742-7843.2012.00863.x >. -
APA
Marson, B. P., Figueiredo, C. E. P. de, & Santos, J. E. T. dos. (2012). Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target. Basic and Clinical Pharmacology and toxicology, 110( 5), 409-415. Recuperado de http://dx.doi.org/10.1111/j.1742-7843.2012.00863.x -
NLM
Marson BP, Figueiredo CEP de, Santos JET dos. Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target [Internet]. Basic and Clinical Pharmacology and toxicology. 2012 ; 110( 5): 409-415.Available from: http://dx.doi.org/10.1111/j.1742-7843.2012.00863.x -
Vancouver
Marson BP, Figueiredo CEP de, Santos JET dos. Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target [Internet]. Basic and Clinical Pharmacology and toxicology. 2012 ; 110( 5): 409-415.Available from: http://dx.doi.org/10.1111/j.1742-7843.2012.00863.x - Matrix metalloproteinases as drug targets in preeclampsia
- Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble Fms-like tyrosine kinase-1 and soluble endogline in preeclampsia
- Interethnic differences in the distribution of clinically relevant vascular endothelial growth factor genetic polymorphisms
- Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions
- Atorvastatina reduz a hipertensão arterial pulmonar causada por embolia pulmonar aguda (EPA) em ratos
- Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism
- eNos haplotype associated with hypertension in obese children and adolescents
- Matrix metalloproteinase-9 genetic variation affect MMP-9 levels in obese children
- Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension
- Hemolysis during cardiac surgery is associated with increased intravascular nitric oxide consumption and perioperative kidney and intestinal tissue damage
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
